Space Institute seeks behavioral health solutions for Mars Mar 13, 2020 The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine is seeking companies with fresh ideas to help guard the minds of future deep-space explorers.
Baylor, University of Houston, announce collaborative grants Mar 9, 2020 Baylor College of Medicine and the University of Houston are teaming up for new research collaborations.
New insight into breast cancer resistance to hormone therapy Mar 5, 2020 New findings suggest that a therapeutic approach must combine two different drugs, a SERD to degrade ER and a MEK inhibitor to inhibit Ras downstream signaling, in order to effectively treat neurofibromin-depleted ER+ breast cancer.
Baylor researchers receive nearly $2.7 million in CPRIT grants Feb 19, 2020 Baylor College of Medicine has been awarded nearly $2.7 million by the Cancer Prevention and Research Institute of Texas (CPRIT) to support new cancer research.
HeartCare study tests genetic risk of cardiovascular disease Feb 19, 2020 Researchers are working with Baylor cardiologists to determine patients’ genetic risk factors for cardiovascular disease
Molecular roadmap boosts fight against endometrial cancer Feb 13, 2020 A study reveals an unprecedented look at the dozens of molecular steps that occur to bring about endometrial cancer, commonly known as uterine cancer.
Lights Out Cancer event raises nearly $1.1 million for research Feb 11, 2020 Baylor College of Medicine’s Lights Out Cancer event raised nearly $1.1 million to support cancer research at Baylor’s Dan L Duncan Comprehensive Cancer Center.
Evenings with Genetics spotlights Turner Syndrome Feb 5, 2020 On Tuesday, Feb. 11, Evenings with Genetics will discuss the genetics and state-of-the art heart care for children with Turner Syndrome.
Cardiovascular disease risk factor targeted for new treatment Feb 5, 2020 Baylor College of Medicine researchers are beginning trials to test two new drugs that directly target Lp(a) levels.
Researchers work to prevent kidney failure after surgery Jan 30, 2020 Scientists have improved their understanding of kidney failure for patients that possess high levels of suPAR protein (soluble urokinase-type plasminogen activator receptor).